## COO: The Cooper Companies, Inc. - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 0.87 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($72.56)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Cooper Companies (COO) Valuation: Reassessing Upside After Earnings Beat, Strong 2026 Outlook and Strategic Review**
- Source: Simply Wall Street | 20251209T130758 | Somewhat-Bullish | Relevance: 98%
- Cooper Companies (COO) recently announced an earnings beat, a strong 2026 outlook, and a strategic review, leading to an 11.32% share price recovery over 30 days, despite a substantial 21.38% drop over the last year. The company is currently considered 6% undervalued, trading at $78.04 against a fair value estimate of $83.00, driven by anticipated free cash flow generation and debt reduction. However, a high P/E ratio and pressure in the contact lens and fertility markets pose risks to the recovery.

**2. Norges Bank Invests $35.06 Million in The Cooper Companies, Inc. $COO**
- Source: MarketBeat | 20251208T104621 | Somewhat-Bullish | Relevance: 98%
-  Norges Bank recently acquired a significant stake in The Cooper Companies, Inc. (NASDAQ:COO), purchasing 492,706 shares valued at approximately $35.06 million during the second quarter. This investment makes Norges Bank a substantial shareholder, owning about 0.25% of the company. The article also details other institutional investor activities, analyst ratings, and insider transactions related to Cooper Companies, highlighting a "Moderate Buy" consensus and a $90.31 average target price.

**3. Cooper Companies price target raised to $88 from $72 at Citi**
- Source: TipRanks | 20251208T140823 | Bullish | Relevance: 98%
- Citi has raised its price target for Cooper Companies (COO) to $88 from $72, while maintaining a Neutral rating on the shares. This adjustment follows the company's better-than-expected fiscal Q4 results, which broke a trend of previous misses. The upgrade reflects a positive outlook on Cooper Companies' recent financial performance.

**4. Cooper Companies (NASDAQ:COO) Price Target Raised to $78.00 at JPMorgan Chase & Co.**
- Source: MarketBeat | 20251206T155856 | Somewhat-Bullish | Relevance: 98%
-  JPMorgan Chase & Co. has raised its price target for Cooper Companies (NASDAQ:COO) from $66.00 to $78.00 while maintaining a "neutral" rating, indicating a potential 5.75% downside from the previous close. This adjustment follows Cooper's strong quarterly performance, exceeding EPS and revenue estimates, and its announcement of a $2.0 billion share buyback program. Despite the "neutral" rating from JPMorgan, the stock holds a consensus "Moderate Buy" rating among analysts with an average target price of $89.54.

**5. Invesco Ltd. Sells 100,819 Shares of The Cooper Companies, Inc. $COO**
- Source: MarketBeat | 20251206T113440 | Somewhat-Bullish | Relevance: 98%
-  Invesco Ltd. reduced its stake in The Cooper Companies, Inc. by 2.1% in the second quarter, selling 100,819 shares and now owning 4,623,938 shares valued at $329 million. Other institutional investors also adjusted their positions in COO, while a director of Cooper Companies, Lawrence Erik Kurzius, purchased 2,000 shares. The company recently announced a $2.00 billion share repurchase program and has received mostly positive ratings from analysts, with an average price target of $90.31.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 10, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Citigroup | $88 | $72 | +22% |
| 2025-12-08 | Morgan Stanley | $83 | $76 | +9% |
| 2025-12-08 | Goldman Sachs | $71 | $64 | +11% |
| 2025-12-05 | Stifel | $95 | $85 | +12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Citigroup | main | Neutral |
| 2025-12-08 | Morgan Stanley | main | Equal-Weight |
| 2025-12-08 | Goldman Sachs | main | Sell |
| 2025-12-05 | Stifel | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.14M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (-1.1%)
- Blackrock Inc.: 7.7% (-0.8%)
- Capital World Invest: 5.3% (+25.7%)
- T. Rowe Price Invest: 4.9% (+33.2%)
- State Street Corpora: 4.3% (-0.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 10 raises (avg +14%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.87 indicates undervaluation relative to growth. Analyst sentiment positive (10 raises, avg +14%). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $15.6B |
| Beta | 1.05 |
| 52W Range | $61.78 - $100.47 |
| Short Interest | 3.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.87 |
| Forward P/E | 15.8 |
| Current P/E | 17.3 |
| YoY Growth | 9.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 2.2% (minimal 5-day change). Below STRENGTH zone by 1.8pp (needs >4.0% for momentum thesis). MRS_5 at 0.3% confirms short-term momentum alignment. AM_20 at 4.3% shows strong absolute momentum above own 20MA. Outperforming sector by 5.6pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 60. Elevated volume (2.2x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.17% (CS: 72) | Neutral |
| RSI_14 | 59.7 | Neutral |
| MACD Histogram | 0.36 | Bullish |
| vs SMA20 | 1.043x | Above |
| vs SMA50 | 1.079x | Above |
| vs SMA200 | 1.043x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $78.04
- **Stop Loss:** $72.56 (7.0% risk)
- **Target:** $89.00 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 91
- **Position Value:** $7,101.64
- **Portfolio %:** 7.10%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-03-05 (Est: $1.03)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.11 | $1.15 | +3.3% |
| 2025Q3 | $1.07 | $1.10 | +3.0% |
| 2025Q2 | $0.93 | $0.96 | +3.3% |
| 2025Q1 | $0.91 | $0.92 | +0.9% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*